FineHeart awarded €7.8m funding by France 2030 program “i-demo”
Non-dilutive financing to support the clinical development of its FLOWMAKER®
Bordeaux, France, March 13, 2024 - FineHeart S.A, a clinical stage medical device company developing innovative devices for cardiology today announces that it has been awarded 7.8 million
euros of non-dilutive funding under the France 2030 program "i-Demo"